SubHero Banner
Text

April 2021

Core topics in this month’s edition include:

  • Bamlanivimab – revocation of emergency use authorization
  • Farxiga (dapagliflozin) - new indication
  • Johnson & Johnson COVID-19 Vaccine - safety update

Download PDF

Text